References
- Howlett A. C., Bonner T. I., Cabral G. A., Casellas P., Devane W. A., Felder C. C., Herkenham M., Martin B. R., Mechoulam R., Pertwee R. G. The IUPHAR Receptor Compendium of Receptor Characterization and Classification, Cannabinoid Receptors. IUPHAR Media. 1998; 97–104
- Matsuda L. A., Lolait S. J., Brownstein B. J., Young A. C., Bonner T. L. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564
- Matsunaga T., Watanabe K., Yamamoto I., Negishi M., Gonzalez F. J., Yoshimura H. cDNA cloning and sequence of CYP2C29 encoding P450MUT‐2, a microsomal aldehyde oxygenase. Biochim. Biophys. Acta 1994; 1184: 299–301
- Watanabe K., Yamamoto I., Oguri K., Yoshimura H. Comparison in mice of pharmacological effects of Δ8‐tetrahydrocannabinol oxidized at 11‐position. Eur. J. Pharmacol. 1980; 63: 1–6
- Watanabe K., Yamamoto I., Yoshimura H. Tolerance and cross‐tolerance development to the cataleptogenic effects of Δ8‐tetrahydrocannabinol and 11‐hydroxy‐Δ8‐tetrahydrocannabinol in mice. Eur. J. Pharmacol. 1983; 94: 349–352
- Watanabe K., Narimatsu S., Yamamoto I., Yoshimura H. Oxygenation mechanism in conversion of aldehyde to carboxylic acid catalyzed by a cytochrome P‐450 isozyme. J. Biol. Chem. 1991; 266: 2709–2711
- Watanabe K., Narimatsu S., Matsunaga T., Yamamoto I., Yoshimura H. A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes. Biochem. Pharmacol. 1993; 46: 405–411
- Watanabe K., Matsunaga T., Yamamoto I., Funae Y., Yoshimura H. Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman. Biol. Pharm. Bull. 1995; 18: 1138–1141
- Yamamoto I. Metabolic activation of marihuana constituents: relations to pharmacological toxicological effects (review). Yakugaku Zasshi 1986; 106: 537–561
- Yamamoto I. Novel drug metabolizing enzymes identified from cannabinoid metabolic studies, and their reaction mechanisms (review). Xenobiotic Metab. Dispos. 1999; 14: 111–119
- Yamamoto I., Watanabe K., Kuzuoka K., Narimatsu S., Yoshimura H. The pharmacological activity of cannabinol and its major metabolite, 11‐hydroxycannabinol. Chem. Pharm. Bull. 1987; 35: 2144–2147
- Yamamoto I., Watanabe K., Narimatsu S., Yoshimura H. Oxygenation mechanism in the oxidation of xenobiotic aldehyde to carboxylic acid by mouse hepatic microsomes. Biochem. Biophys. Res. Commun. 1988; 153: 779–782
- Yamamoto I., Nagai K., Watanabe K., Matsunaga T., Yoshimura H. A novel metabolite, an oxepin formed from cannabidiol with guinea pig hepatic microsomes. J. Pharm. Pharmacol. 1995a; 47: 683–686
- Yamamoto I., Watanabe K., Narimatsu S., Yoshimura H. Recent advances in the metabolism of cannabinoids (review). Int. J. Biochem. Cell Biol. 1995b; 27: 741–746
- Yamamoto I., Kimura T., Kamei A., Yoshida H., Watanabe K., Ho I. K., Yoshimura H. Competitive inhibition of Δ8‐tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding. Biol. Pharm. Bull. 1998; 21: 408–410